MaxLinear director-linked trust sells 11,000 shares
MAXLINEAR, INC director Thomas E. Pardun reported an insider transaction involving common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MAXLINEAR, INC director Thomas E. Pardun reported an insider transaction involving common stock. On May 26, 2026, the Thomas E. Pardun Irrevocable Trust, an entity associated with him, completed an open-market sale of 11,000 common shares at $105 per share.
Following this sale, the trust held 55,252 common shares indirectly, while Pardun also held 12,141 common shares directly. The filing reflects a net reduction of 11,000 shares in his reported holdings, combining both direct and indirect positions disclosed.
Insights
Director-linked trust sold 11,000 MaxLinear shares, but sizable holdings remain.
The filing shows an open-market sale of 11,000 MaxLinear common shares at $105 per share by the Thomas E. Pardun Irrevocable Trust, which is associated with director Thomas E. Pardun. This is categorized as a non-derivative, open-market sale.
After the transaction, reported indirect holdings through the trust total 55,252 shares, and direct holdings total 12,141 shares. With no derivative positions listed and continuing sizable ownership, this looks like a portfolio adjustment rather than a transformative change. Overall impact on the investment case appears limited based on this filing alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 11,000 | $105.00 | $1.16M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Shares held by the Thomas E. Pardun Irrevocable Trust (the "Trust"). The shares now reported as being owned by the Trust were transferred from direct ownership on October 28, 2020.
Key Figures
Key Terms
open-market sale financial
indirect ownership financial
Irrevocable Trust financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did MaxLinear (MXL) report for Thomas E. Pardun?
What are Thomas E. Pardun’s holdings in MaxLinear (MXL) after the sale?
Does the MaxLinear (MXL) Form 4 show any derivative securities for Thomas E. Pardun?
AI-generated analysis. How Rhea-AI works. Not financial advice.